New York Life Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.12M | Buy |
58,704
+543
| +0.9% | +$47.4K | 0.05% | 324 |
|
2025
Q1 | $3.97M | Sell |
58,161
-445
| -0.8% | -$30.4K | 0.04% | 366 |
|
2024
Q4 | $4.56M | Sell |
58,606
-600
| -1% | -$46.7K | 0.04% | 345 |
|
2024
Q3 | $3.97M | Sell |
59,206
-1,338
| -2% | -$89.7K | 0.04% | 411 |
|
2024
Q2 | $6.86M | Buy |
60,544
+2,211
| +4% | +$251K | 0.07% | 256 |
|
2024
Q1 | $8.09M | Sell |
58,333
-2,141
| -4% | -$297K | 0.08% | 226 |
|
2023
Q4 | $7.5M | Sell |
60,474
-118
| -0.2% | -$14.6K | 0.08% | 226 |
|
2023
Q3 | $5.65M | Sell |
60,592
-245
| -0.4% | -$22.9K | 0.06% | 284 |
|
2023
Q2 | $7.82M | Sell |
60,837
-172
| -0.3% | -$22.1K | 0.08% | 230 |
|
2023
Q1 | $7.09M | Sell |
61,009
-124
| -0.2% | -$14.4K | 0.08% | 256 |
|
2022
Q4 | $6.92M | Sell |
61,133
-1,014
| -2% | -$115K | 0.08% | 253 |
|
2022
Q3 | $5.01M | Sell |
62,147
-420
| -0.7% | -$33.8K | 0.06% | 307 |
|
2022
Q2 | $4.66M | Buy |
+62,567
| New | +$4.66M | 0.05% | 324 |
|